Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Moderate exercise improves function and increases adiponectin in the mdx mouse model of muscular dystrophy

View through CrossRef
AbstractThe loss of dystrophin produces a mechanically fragile sarcolemma, causing muscle membrane disruption and muscle loss. The degree to which exercise alters muscular dystrophy has been evaluated in humans with Duchenne Muscular Dystrophy (DMD) and in mouse models including the mdx mouse but with inconsistent findings. We now examined two different levels of exercise, moderate and low intensity, in the mdx mouse model in the DBA2J background. mdx mice at 4–5 months of age were subjected to two different doses of exercise. We found a dose-dependent benefit for low and moderate exercise, defined as 4 m/min or 8 m/min, for 30 minutes three times a week. After six months, exercised mdx mice showed improved tetanic and specific force compared to the sedentary group. We also observed increased respiratory capacity manifesting as greater minute volume, as well as enhanced cardiac function mitigating the decline of fractional shortening that is normally seen. Exercised mdx mice also showed a dose-dependent increase in serum adiponectin with a concomitant reduced adipocyte cross sectional area. These findings identify moderate intensity exercise as a means to improve muscle performance in the mdx DBA2J mice and suggest serum adiponectin as a biomarker for beneficial exercise effect in DMD.
Title: Moderate exercise improves function and increases adiponectin in the mdx mouse model of muscular dystrophy
Description:
AbstractThe loss of dystrophin produces a mechanically fragile sarcolemma, causing muscle membrane disruption and muscle loss.
The degree to which exercise alters muscular dystrophy has been evaluated in humans with Duchenne Muscular Dystrophy (DMD) and in mouse models including the mdx mouse but with inconsistent findings.
We now examined two different levels of exercise, moderate and low intensity, in the mdx mouse model in the DBA2J background.
mdx mice at 4–5 months of age were subjected to two different doses of exercise.
We found a dose-dependent benefit for low and moderate exercise, defined as 4 m/min or 8 m/min, for 30 minutes three times a week.
After six months, exercised mdx mice showed improved tetanic and specific force compared to the sedentary group.
We also observed increased respiratory capacity manifesting as greater minute volume, as well as enhanced cardiac function mitigating the decline of fractional shortening that is normally seen.
Exercised mdx mice also showed a dose-dependent increase in serum adiponectin with a concomitant reduced adipocyte cross sectional area.
These findings identify moderate intensity exercise as a means to improve muscle performance in the mdx DBA2J mice and suggest serum adiponectin as a biomarker for beneficial exercise effect in DMD.

Related Results

An obesogenic diet alters muscle function in mdx mice
An obesogenic diet alters muscle function in mdx mice
Duchenne muscular dystrophy (DMD) is a progressive muscle degenerative disease that occurs in 1 in 5000 boys born worldwide. DMD is caused by the absence of a functional dystrophin...
Defective regulation of energy metabolism in mdx-mouse skeletal muscles
Defective regulation of energy metabolism in mdx-mouse skeletal muscles
Our previous finding of a reduced energy metabolism in slow- and fast-twitch skeletal muscle fibres from the murine model of Duchenne muscular dystrophy (the mdx mouse) led us to e...
Adiponectin stimulates glucose uptake in mouse blastocysts and embryonic carcinoma cells
Adiponectin stimulates glucose uptake in mouse blastocysts and embryonic carcinoma cells
Abstract Preimplantation embryos are sensitive to maternal hormones affecting embryonic signal transduction and metabolic functions. We examined whether adiponect...
Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin‐Deficient Hearts
Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin‐Deficient Hearts
Background Cardiomyopathy is a leading cause of mortality among Duchenne muscular dystrophy patients and lacks effective therapies. Phosphodiesterase type 5 is ...
Challenges in developing gene therapy against Duchenne muscular dystrophy
Challenges in developing gene therapy against Duchenne muscular dystrophy
Duchenne muscular dystrophy is a progressive X-linked recessive neuromuscular disorder resulting from pathogenic mutations in the DMD gene, which codes dystrophin. It is one of the...

Back to Top